e-learning
resources
Paris 2018
Monday, 17.09.2018
Challenges in tuberculosis care
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Determinants of lymph node resolution in patients of tubercular lymphadenitis treated with anti tuberculous chemotherapy.
A. Khurana (Bhopal, India), V. Gupta (Bhopal, India), D. Joshi (Bhopal, India), A. Goyal (Bhopal, India), K. Pawar (Bhopal, India), A. Pakhare (Bhopal, India)
Source:
International Congress 2018 – Challenges in tuberculosis care
Session:
Challenges in tuberculosis care
Session type:
Thematic Poster
Number:
2686
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Khurana (Bhopal, India), V. Gupta (Bhopal, India), D. Joshi (Bhopal, India), A. Goyal (Bhopal, India), K. Pawar (Bhopal, India), A. Pakhare (Bhopal, India). Determinants of lymph node resolution in patients of tubercular lymphadenitis treated with anti tuberculous chemotherapy.. 2686
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Diagnosis of tuberculosis lymph node disease (TBLN): Problems with mediastinal disease
Source: Annual Congress 2011 - Pulmonary and extrapulmonary tuberculosis
Year: 2011
Spontaneous chylothorax revealing a mediastinal and abdominal lymph node tuberculosis
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1
Year: 2014
Etiology of mediastinal lymph node enlargement in patients who underwent EBUS-TBNA.
Source: International Congress 2019 – Pleural disease: applying the evidence
Year: 2019
Characteristics of cases with lymph node tuberculosis
Source: Eur Respir J 2005; 26: Suppl. 49, 427s
Year: 2005
Microbiological study of mediastinal lymph node biopsy from patients with sarcoidosis and lung cancer
Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes
Year: 2018
Mediastinal tuberculous lymphadenitis (analysis of 41 cases)
Source: Eur Respir J 2002; 20: Suppl. 38, 551s
Year: 2002
A retrospective analysis of lymph node sampling methods in patients with TB lymphadenitis
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management III
Year: 2013
A case of mediastinal tuberculous lymphadenitis presenting as a mediastinal mass with dysphagia
Source: Annual Congress 2007 - Difficult tuberculosis cases II
Year: 2007
EBUS-TBNA in sarcoidosis and lymphoma: Exploring the importance of culture on lymph nodes
Source: International Congress 2015 – Endoscopic ultrasound: an essential tool for interventional pulmonology
Year: 2015
Secondary lymph node involvement in patients with pulmonary metastases
Source: Eur Respir J 2007; 30: Suppl. 51, 273s
Year: 2007
EBUS-TBNA in the rapid microbiological diagnosis of drug-resistant mediastinal tuberculous lymphadenopathy
Source: ERJ Open Res, 5 (4) 00008-2019; 10.1183/23120541.00008-2019
Year: 2019
Diagnosis of mediastinal adenopathies in patients with extrathoraic tumors: role of EBUS-TBNA
Source: Virtual Congress 2020 – Endobronchial ultrasound: from rookie to pro
Year: 2020
The neck as mediastinal extension: diagnosis of sarcoidosis by core biopsy of cervical lymph nodes
Source: International Congress 2016 – Sarcoidosis
Year: 2016
The role of number of lymph node passes and methods of pathological examination in the adequacy specimens of EBUS-TBNA in the verification of mediastinal lymphadenopathy
Source: Annual Congress 2013 –VATS, interventional endoscopy and tracheal surgery
Year: 2013
Tuberculous mediastinal lymphadenopathy – clinical presentations
Source: Eur Respir J 2007; 30: Suppl. 51, 656s
Year: 2007
Role of EBUS-guided TBNA in CT reported isolated tubercular mediastinal lymphadenopathy
Source: International Congress 2016 – Active and latent tuberculosis: biomarkers
Year: 2016
Enlarged mediastinal lymph nodes in patients without a diagnosis; consider EUS-FNA!
Source: Eur Respir J 2003; 22: Suppl. 45, 57s
Year: 2003
Diagnostic performance of EBUS-TBNA in patients with mediastinal lymphadenopathy and extrathoracic malignancy
Source: Annual Congress 2013 –TBNA, EBUS-TBNA and new technologies for diagnostic bronchoscopy
Year: 2013
PET-CT high-SUV mediastinal lymph nodes (MLN) in primary or treated extrathoracic malignancy – “Not all that lights up is malignant”
Source: International Congress 2017 – EBUS
Year: 2017
The contribution of transbronchial lymph node aspirates (TBNA) to the diagnosis of mediastinal granulomatous lymphadenitis (MGL)
Source: Eur Respir J 2005; 26: Suppl. 49, 532s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept